Stock listing
Nanexa Ab
Selected listing: NANEXA · OMXSTO · SEK · SE
Nanexa Ab (Stockholm:NANEXA), Health Technology. Latest release Sep 25, 2026: Nanexa and Novo enter into EUR 1.165 billion global license and collaboration…
- Ticker
- Stockholm:NANEXA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- Stockholm
- Currency
- SEK
About Nanexa Ab
Nanexa Ab is a public company listed on the Swedish market under the ticker NANEXA. Nanexa focuses on developing innovative drug delivery systems, aiming to enhance the effectiveness of treatments in the pharmaceutical industry.
Latest news from Nanexa Ab
Nanexa and Novo enter into EUR 1.165 billion global license and collaboration agreement for long-acting injectables
September 25, 2026
Nanexa publishes interim report for April - June 2026
August 27, 2026
Nanexa publishes interim report for January-March 2026
April 29, 2026
Nanexa resolves on set-off of outstanding loan
April 28, 2026
Nanexa announces exercise of warrants
April 2, 2026